{
    "id": "3633896c-95f9-f86b-e063-6294a90aad7c",
    "indications": "PYRUKYND is indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.",
    "contraindications": "PYRUKYND is taken orally with or without food. The tablets should be swallowed whole. Do not split, crush, chew, or dissolve the tablets.",
    "warningsAndPrecautions": "How Supplied\n                  \n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                            \n    \n     \n                                 PYRUKYND 28-Day Packs\n                              \n                           \n                        \n                        \n                           \n                              Tablet Strength\n                           \n                            \n    \n     Description\n                           \n                            \n    \n     Imprint\n                           \n                            \n    \n     NDC\n                           \n                        \n                        \n                           5 mg\n                            Round, blue, film-coated tablets\n                            \"M5\" printed on one side\n                            71334-205-05\n                        \n                        \n                           20 mg\n                            Round, blue, film-coated tablets\n                            \"M20\" printed on one side\n                            71334-210-20\n                        \n                        \n                           50 mg\n                            Oblong, blue, film-coated tablets\n                            \"M50\" printed on one side\n                            71334-215-50\n                        \n                     \n                  \n                  \n                     \n                     \n                     \n                     \n                     \n                     \n                        \n                            \n    \n     \n                                 PYRUKYND Taper Packs\n                              \n                           \n                        \n                        \n                           \n                              Tablet strength(s)\n                           \n                            \n    \n     Blister Wallet Configuration\n                           \n                            \n    \n     Tablet Description\n                           \n                            \n    \n     Imprint\n                           \n                            \n    \n     NDC\n                           \n                        \n                        \n                           5 mg\n                            5 mg blister wallet containing 7 tablets\n                            round, blue, film-coated tablets\n                           \"M5\" printed on one side \n     \n                              \n                           \n                           71334-220-11\n                        \n                        \n                           \n                              20 mg and 5 mg\n                           \n                            \n    \n     \n                                 20 mg blister wallet containing 7 tablets\n                                 5 mg blister wallet containing 7 tablets\n                              \n                           \n                           \n                                round, blue, film-coated tablets \n       round, blue, film-coated tablets\n    \n                           \"M20\" \n       printed on one side \n       \"M5\" printed on one side\n    \n                           71334-225-12\n                        \n                        \n                           50 mg and 20 mg\n                           \n                              \n                                 50 mg blister wallet containing 7 tablets\n                                 20 mg blister wallet containing 7 tablets\n                              \n                           \n                           oblong, blue, film- coated tablets \n       round, blue, film-coated tablets\n    \n                           \n                              \"M50\"printed on one side \n     \n                              \"M20\"printed on one side\n   \n    \n                           71334-230-13\n                        \n                     \n                  \n                  \n                     Storage\n                  \n                  \n                      Store at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F)\n \n  [see USP Controlled Room Temperature]. Store the blister wallets in the original carton until use.",
    "adverseReactions": "None",
    "ingredients": [
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM STEARYL FUMARATE",
            "code": "7CV7WJK4UI"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "MITAPIVAT",
            "code": "2WTV10SIKH"
        }
    ],
    "organization": "Agios Pharmaceuticals, Inc.",
    "name": "PYRUKYND",
    "effectiveTime": "20250528"
}